GLOBAL INJECTABLE DRUG DELIVERY MARKET 2019-2027


MARKET OUTLOOK
According to an analysis by a Triton Market Research, the global injectable drug delivery market is predicted to grow at a CAGR of 8.67% during the forecasting period 2019-2027.
The increasing geriatric population, the advancement in the technologies and the growing occurrences of auto-immune diseases are some of the key factors driving the global market of the injectable drug delivery. However, the high manufacturing cost is hampering the market growth. Besides, developments in alternate drug delivery systems and the stringent regulations are posing as the challenges to market growth. But the advancement of the innovative injectable system is likely to create opportunities for overall market growth.
REGIONAL OUTLOOK
The global market report covers the countries from North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa.
Asia-Pacific is expected to be the fastest-growing market of injectable drug delivery over the forecasted period. The increase in the elderly population in Asia-Pacific countries is one of the key factors of market growth. The rise in the life expectancy of the people is expected to create high demand for injectable drug delivery systems. With the increase in the disposable income of the region, there is a demand for better healthcare products. 
The region is experiencing an increase in the cases of chronic disorders like diabetes, cardiovascular diseases and auto-immune diseases, leading to the market growth of injectable drug delivery systems. Moreover, the ever-increasing population in the countries in Asia-Pacific region, an increase in the demand for vaccines, is expected. Vaccines are the most preferred method of drug administration using prefilled syringes. 
COMPETITIVE OUTLOOK
The major companies in the injectable drug delivery market are Baxter, Becton, Dickinson and Company, Elcam Medical, Eli Lilly and Company, GERRESHEIMER, INJEX, Novartis AG, Novo Nordis A/S, Pfizer Inc, SANOFI, SCHOTT AG, Terumo Corporation, Teva Pharmaceutical Industries Ltd, West Pharmaceutical Services Inc and Ypsomed. 
Incorporated in 1931, Baxter is one of the leading companies that deal with the development, manufacturing, and marketing of hospital equipment for different disorders. The company is operated in two major segments - hospitals and renal. The company offers its products to hospitals, nursing homes, kidney dialysis centers, rehab centers and research laboratories. Headquartered in  Illinois, the United States, the company has a strong business presence in more than 100 countries.
TABLE OF CONTENT 
1. GLOBAL INJECTABLE DRUG DELIVERY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITIONS
2.2. PORTER’S FIVE FORCES MODEL
2.2.1. THREAT OF NEW ENTRANT
2.2.2. THREAT OF SUBSTITUTE
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. INTENSITY OF COMPETITIVE RIVALRY
2.3. PATENT OUTLOOK
2.4. MARKET SHARE OUTLOOK
2.5. KEY INSIGHT
2.6. KEY BUYING CRITERIA
2.7. LEGAL REQUIREMENT
2.8. REGULATORY FRAMEWORK
2.9. MARKET ATTRACTIVENESS INDEX
2.10. MARKET DRIVERS
2.10.1. INCREASING GERIATRIC POPULATION
2.10.2. TECHNOLOGICAL ADVANCEMENT
2.10.3. GROWING OCCURRENCE OF AUTO-IMMUNE DISEASES
2.11.  MARKET RESTRAINT
2.11.1. HIGH MANUFACTURING COST OF THE INJECTABLE DRUG DELIVERY
2.12. MARKET OPPORTUNITY
2.12.1. DEVELOPMENT OF BETTER INJECTABLE SYSTEMS
2.13. MARKET CHALLENGES
2.13.1. DEVELOPMENTS IN THE ALTERNATE DRUG DELIVERY SYSTEM
2.13.2. STRINGENT REGULATIONS
3. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY  DEVICE TYPE
3.1. PEN INJECTOR
3.2. AUTO?INJECTOR
3.3. NEEDLE-FREE INJECTOR
3.3.1. GAS?BASED NEEDLE?FREE INJECTOR
3.3.2. SPRING?BASED NEEDLE?FREE INJECTOR
3.3.3. OTHER NEEDLE-FREE INJECTOR
3.4. PREFILLED SYRINGE
3.4.1. GLASS PREFILLED SYRINGE
3.4.2. PLASTIC PREFILLED SYRINGE
4. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY  ROUTE OF ADMINISTRATION
4.1. SUBCUTANEOUS
4.2. INTRAMUSCULAR
4.3. INTRAVENOUS (IV)
4.4. OTHER ROUTE OF ADMINISTRATION
5. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY  END-USER
5.1. CLINICS/ PHYSICIAN OFFICES
5.2. AMBULATORY CARE
5.3. HOSPITAL
5.4. HOME BASED
5.5. OTHERS END-USER
6. INJECTABLE DRUG DELIVERY MARKET – REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. MARKET BY DEVICE TYPE
6.1.2. MARKET BY ROUTE OF ADMINISTRATION
6.1.3. MARKET BY END-USER
6.1.4. COUNTRY ANALYSIS
6.1.4.1. THE UNITED STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET BY DEVICE TYPE
6.2.2. MARKET BY ROUTE OF ADMINISTRATION
6.2.3. MARKET BY END-USER
6.2.4. COUNTRY ANALYSIS
6.2.4.1. THE UNITED KINGDOM
6.2.4.2. GERMANY
6.2.4.3. FRANCE
6.2.4.4. ITALY
6.2.4.5. SPAIN
6.2.4.6. RUSSIA
6.2.4.7. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. MARKET BY DEVICE TYPE
6.3.2. MARKET BY ROUTE OF ADMINISTRATION
6.3.3. MARKET BY END-USER
6.3.4. COUNTRY ANALYSIS
6.3.4.1. JAPAN
6.3.4.2. CHINA
6.3.4.3. AUSTRALIA & NEW ZEALAND
6.3.4.4. INDIA
6.3.4.5. SOUTH KOREA
6.3.4.6. ASEAN COUNTRIES
6.3.4.7. REST OF ASIA PACIFIC
6.4. LATIN AMERICA
6.4.1. MARKET BY DEVICE TYPE
6.4.2. MARKET BY ROUTE OF ADMINISTRATION
6.4.3. MARKET BY END-USER
6.4.4. COUNTRY ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. REST OF LATIN AMERICA
6.5. MIDDLE EAST AND AFRICA
6.5.1. MARKET BY DEVICE TYPE
6.5.2. MARKET BY ROUTE OF ADMINISTRATION
6.5.3. MARKET BY END-USER
6.5.4. COUNTRY ANALYSIS
6.5.4.1. SAUDI ARABIA
6.5.4.2. TURKEY
6.5.4.3. UNITED ARAB EMIRATES
6.5.4.4. SOUTH AFRICA
6.5.4.5. REST OF MIDDLE EAST AND AFRICA
7. COMPANY PROFILES
7.1. BAXTER 
7.2. BECTON, DICKINSON AND COMPANY (BD)
7.3. ELCAM MEDICAL
7.4. ELI LILLY AND COMPANY
7.5. GERRESHEIMER 
7.6. INJEX 
7.7. NOVARTIS AG
7.8. NOVO NORDISK A/S
7.9. PFIZER INC
7.10. SANOFI
7.11. SCHOTT AG
7.12. TERUMO CORPORATION
7.13. TEVA PHARMACEUTICAL INDUSTRIES LTD
7.14. WEST PHARMACEUTICAL SERVICES INC
7.15. YPSOMED
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS
 
 
 
 
 
 
 
LIST OF TABLES 
TABLE 1 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY REGION, 2019-2027 ($ MILLION) 
TABLE 2 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2027 ($ MILLION) 
TABLE 3 DIFFERENT TYPES OF INSULIN PEN INJECTORS 
TABLE 4 MARKETED NEEDLE-FREE INJECTORS PRODUCTS 
TABLE 5 GLOBAL NEEDLE-FREE INJECTOR BY TYPE, 2019-2027 ($ MILLION) 
TABLE 6 LYOPHILIZED DRUGS  USED IN PREFILLED SYRINGE 
TABLE 7 GLOBAL PREFILLED SYRINGE BY TYPE, 2019-2027 ($ MILLION) 
TABLE 8 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) 
TABLE 9 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) 
TABLE 10 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY REGION, 2019-2027 ($ MILLION) 
TABLE 11 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2027 ($ MILLION) 
TABLE 12 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) 
TABLE 13 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) 
TABLE 14 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION) 
TABLE 15 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2027 ($ MILLION) 
TABLE 16 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) 
TABLE 17 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) 
TABLE 18 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION) 
TABLE 19 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2027 ($ MILLION) 
TABLE 20 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) 
TABLE 21 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) 
TABLE 22 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION) 
TABLE 23 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2027 ($ MILLION) 
TABLE 24 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) 
TABLE 25 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) 
TABLE 26 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION) 
TABLE 27 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2027 ($ MILLION) 
TABLE 28 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) 
TABLE 29 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) 
TABLE 30 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIST OF FIGURES 
FIGURE 1 GLOBAL INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 2 COMPANY MARKET SHARE OUTLOOK 2017 (%) 
FIGURE 3 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY PEN INJECTOR, 2019-2027 ($ MILLION) 
FIGURE 4 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY AUTO?INJECTOR, 2019-2027 ($ MILLION) 
FIGURE 5 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY NEEDLE-FREE INJECTOR, 2019-2027 ($ MILLION) 
FIGURE 6 GLOBAL NEEDLE-FREE INJECTOR MARKET, BY GAS?BASED NEEDLE?FREE INJECTOR, 2019-2027 ($ MILLION) 
FIGURE 7 GLOBAL NEEDLE-FREE INJECTOR MARKET, BY SPRING?BASED NEEDLE?FREE INJECTOR, 2019-2027 ($ MILLION) 
FIGURE 8 GLOBAL NEEDLE-FREE INJECTOR MARKET, BY OTHER NEEDLE-FREE INJECTOR, 2019-2027 ($ MILLION) 
FIGURE 9 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY PREFILLED, 2019-2027 ($ MILLION) 
FIGURE 10 GLOBAL PREFILLED SYRINGE MARKET, BY GLASS PREFILLED SYRINGE, 2019-2027 ($ MILLION) 
FIGURE 11 GLOBAL PREFILLED SYRINGES MARKET, BY PLASTIC PREFILLED SYRINGE, 2019-2027 ($ MILLION) 
FIGURE 12 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY SUBCUTANEOUS, 2019-2027 ($ MILLION) 
FIGURE 13 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY INTRAMUSCULAR, 2019-2027 ($ MILLION) 
FIGURE 14 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY INTRAVENOUS, 2019-2027 ($ MILLION) 
FIGURE 15 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY OTHER ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) 
FIGURE 16 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY CLINICS/ PHYSICIAN OFFICES, 2019-2027 ($ MILLION) 
FIGURE 17 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY AMBULATORY CARE, 2019-2027 ($ MILLION) 
FIGURE 18 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY HOSPITAL, 2019-2027 ($ MILLION) 
FIGURE 19 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY HOME BASED, 2019-2027 ($ MILLION) 
FIGURE 20 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY OTHER END-USER, 2019-2027 ($ MILLION) 
FIGURE 21 THE UNITED STATES INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 22 CANADA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 23 THE UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 24 GERMANY INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 25 FRANCE INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 26 ITALY INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 27 SPAIN INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 28 RUSSIA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 29 REST OF EUROPE INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 30 JAPAN INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 31 CHINA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 32 AUSTRALIA & NEW ZEALAND INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 33 INDIA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 34 SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 35 ASEAN COUNTRIES INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 36 REST OF ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 37 BRAZIL INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 38 MEXICO INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 39 REST OF LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 40 SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 41 TURKEY INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 42 UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 43 SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 44 REST OF MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION)

LIST OF TABLES TABLE 1 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY REGION, 2019-2027 ($ MILLION) TABLE 2 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2027 ($ MILLION) TABLE 3 DIFFERENT TYPES OF INSULIN PEN INJECTORS TABLE 4 MARKETED NEEDLE-FREE INJECTORS PRODUCTS TABLE 5 GLOBAL NEEDLE-FREE INJECTOR BY TYPE, 2019-2027 ($ MILLION) TABLE 6 LYOPHILIZED DRUGS USED IN PREFILLED SYRINGE TABLE 7 GLOBAL PREFILLED SYRINGE BY TYPE, 2019-2027 ($ MILLION) TABLE 8 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) TABLE 9 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) TABLE 10 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY REGION, 2019-2027 ($ MILLION) TABLE 11 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2027 ($ MILLION) TABLE 12 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) TABLE 13 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) TABLE 14 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION) TABLE 15 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2027 ($ MILLION) TABLE 16 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) TABLE 17 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) TABLE 18 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION) TABLE 19 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2027 ($ MILLION) TABLE 20 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) TABLE 21 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) TABLE 22 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION) TABLE 23 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2027 ($ MILLION) TABLE 24 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) TABLE 25 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) TABLE 26 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION) TABLE 27 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2027 ($ MILLION) TABLE 28 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) TABLE 29 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) TABLE 30 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION) LIST OF FIGURES FIGURE 1 GLOBAL INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 2 COMPANY MARKET SHARE OUTLOOK 2017 (%) FIGURE 3 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY PEN INJECTOR, 2019-2027 ($ MILLION) FIGURE 4 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY AUTO?INJECTOR, 2019-2027 ($ MILLION) FIGURE 5 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY NEEDLE-FREE INJECTOR, 2019-2027 ($ MILLION) FIGURE 6 GLOBAL NEEDLE-FREE INJECTOR MARKET, BY GAS?BASED NEEDLE?FREE INJECTOR, 2019-2027 ($ MILLION) FIGURE 7 GLOBAL NEEDLE-FREE INJECTOR MARKET, BY SPRING?BASED NEEDLE?FREE INJECTOR, 2019-2027 ($ MILLION) FIGURE 8 GLOBAL NEEDLE-FREE INJECTOR MARKET, BY OTHER NEEDLE-FREE INJECTOR, 2019-2027 ($ MILLION) FIGURE 9 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY PREFILLED, 2019-2027 ($ MILLION) FIGURE 10 GLOBAL PREFILLED SYRINGE MARKET, BY GLASS PREFILLED SYRINGE, 2019-2027 ($ MILLION) FIGURE 11 GLOBAL PREFILLED SYRINGES MARKET, BY PLASTIC PREFILLED SYRINGE, 2019-2027 ($ MILLION) FIGURE 12 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY SUBCUTANEOUS, 2019-2027 ($ MILLION) FIGURE 13 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY INTRAMUSCULAR, 2019-2027 ($ MILLION) FIGURE 14 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY INTRAVENOUS, 2019-2027 ($ MILLION) FIGURE 15 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY OTHER ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) FIGURE 16 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY CLINICS/ PHYSICIAN OFFICES, 2019-2027 ($ MILLION) FIGURE 17 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY AMBULATORY CARE, 2019-2027 ($ MILLION) FIGURE 18 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY HOSPITAL, 2019-2027 ($ MILLION) FIGURE 19 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY HOME BASED, 2019-2027 ($ MILLION) FIGURE 20 GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY OTHER END-USER, 2019-2027 ($ MILLION) FIGURE 21 THE UNITED STATES INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 22 CANADA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 23 THE UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 24 GERMANY INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 25 FRANCE INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 26 ITALY INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 27 SPAIN INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 28 RUSSIA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 29 REST OF EUROPE INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 30 JAPAN INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 31 CHINA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 32 AUSTRALIA & NEW ZEALAND INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 33 INDIA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 34 SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 35 ASEAN COUNTRIES INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 36 REST OF ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 37 BRAZIL INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 38 MEXICO INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 39 REST OF LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 40 SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 41 TURKEY INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 42 UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 43 SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 44 REST OF MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by Triton Market Research

GLOBAL RECYCLED GLASS MARKET 2020-2028

MARKET OUTLOOK According to Triton, the global recycled glass market is expected to display a positive market trend over the forecast years 2020-2028, exhibiting a CAGR of 6.02% (by revenue) and 6.25% (by volume). Glass has several advantageous prope...

GLOBAL PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK As per an analysis by the Triton Market Research on the global PP nonwoven market, it is estimated that the industry would show growth at a CAGR of 7.05% in the period 2020-2028. PP nonwoven material is used in the production of diaper...

NORTH AMERICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK A Triton Market Research report on the North American PP nonwoven market depicts that the market is likely to show growth at a CAGR of 6.87% in the forecast period between 2020 and 2028. The United States and Canada comprises the North...

MIDDLE EAST AND AFRICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK As per a Triton Market Research report, the PP nonwoven market in the Middle East and Africa is set to accelerate at a CAGR of 8.51% during the forecast period 2020-2028. Saudi Arabia, Turkey, the United Arab Emirates and the Rest of t...

LATIN AMERICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK A Triton Market Research report illustrates that the Latin American PP nonwoven market would exhibit a CAGR of 7.28% during the estimated period 2020-2028. Brazil, Mexico and the Rest of Latin America together form the PP nonwoven mark...

Publisher: Triton Market Research